BIBW 2992 (Afatinib) vs Gemcitabine-cisplatin in 1st Line Non-small Cell Lung Cancer (NSCLC)
Clinical trial NCT01121393 · COMPLETED
Trial details
- NCT number
- NCT01121393
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-04-19
- Primary completion
- 2017-11-23
- Enrollment
- 364
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.